|   encounter_num | encounter_date   |   document_num | document_title                                                                                           |
|----------------:|:-----------------|---------------:|:---------------------------------------------------------------------------------------------------------|
|               1 | 2017-10-12       |              1 | Pre-Op History & Physical – ESRD due to diabetic nephropathy; scheduled deceased donor kidney transplant |
|               1 | 2017-10-12       |              2 | Transplant Surgery Operative Note – Deceased Donor Kidney Transplant (right iliac fossa)                 |
|               1 | 2017-10-12       |              3 | Immediate Post-Op ICU Admission Note – reperfusion, Doppler signals present                              |
|               2 | 2017-10-13       |              1 | Nephrology Inpatient Progress Note – POD#1, urine output improving                                       |
|               2 | 2017-10-13       |              2 | Immunosuppression Initiation & Dosing Plan – Tacrolimus/MMF/Prednisone                                   |
|               3 | 2017-10-16       |              1 | Discharge Summary – Post-Kidney Transplant (DDKT)                                                        |
|               3 | 2017-10-16       |              2 | Pharmacy Medication Reconciliation & Education – adherence counseling                                    |
|               4 | 2017-10-20       |              1 | Transplant Nephrology Clinic Visit – 1 Week Post-Transplant                                              |
|               5 | 2017-11-10       |              1 | Transplant Nephrology Clinic Visit – 1 Month                                                             |
|               5 | 2017-11-10       |              2 | DSA Monitoring Report – Baseline screen (negative)                                                       |
|               6 | 2018-01-12       |              1 | Transplant Nephrology Clinic Visit – 3 Months                                                            |
|               6 | 2018-01-12       |              2 | BK Virus PCR – Screening (not detected)                                                                  |
|               6 | 2018-01-12       |              3 | Tacrolimus Trough Monitoring Summary – dose adjustments                                                  |
|               7 | 2018-04-20       |              1 | Transplant Nephrology Clinic Visit – 6 Months                                                            |
|               8 | 2018-07-12       |              1 | Transplant Nephrology Clinic Visit – 9 Months                                                            |
|               9 | 2018-10-12       |              1 | Allograft Surveillance Biopsy Procedure Note – 12 Months                                                 |
|               9 | 2018-10-12       |              2 | Pathology Report – 12-Month Biopsy (Banff i0 t0 g0 ptc0, C4d negative)                                   |
|               9 | 2018-10-12       |              3 | Nephrology Clinic Visit – Annual assessment                                                              |
|              10 | 2019-02-15       |              1 | Infectious Disease Consult – Low-Level CMV Viremia                                                       |
|              10 | 2019-02-15       |              2 | Antiviral Therapy Plan & Monitoring – valganciclovir dosing                                              |
|              11 | 2019-10-14       |              1 | Transplant Nephrology Clinic Visit – Stable allograft function                                           |
|              12 | 2020-06-01       |              1 | DSA Monitoring Report – New Class II DSA (DQ7 MFI ~3200)                                                 |
|              12 | 2020-06-01       |              2 | Allograft Biopsy Procedure Note – Indication: rising creatinine                                          |
|              12 | 2020-06-01       |              3 | Pathology Report – Borderline TCMR (i1 t1), no ABMR                                                      |
|              12 | 2020-06-01       |              4 | Treatment Plan – Methylpred pulse; MMF increase; consider IVIG                                           |
|              13 | 2020-07-15       |              1 | Transplant Nephrology Follow-Up – Post-steroid pulse; tacrolimus trough adjustment                       |
|              14 | 2021-03-10       |              1 | BK Virus PCR – 12,000 copies/mL (viremia)                                                                |
|              14 | 2021-03-10       |              2 | Immunosuppression Adjustment Note – Hold MMF; lower tacrolimus                                           |
|              15 | 2021-05-20       |              1 | BK Virus PCR – Declining to 1,200 copies/mL                                                              |
|              15 | 2021-05-20       |              2 | Nephrology Visit – Creatinine stable; monitor                                                            |
|              16 | 2022-08-18       |              1 | Nephrology Visit – Rising creatinine; proteinuria 1.2 g/day                                              |
|              16 | 2022-08-18       |              2 | DSA Monitoring – DQ7 MFI 5200; C1q positive                                                              |
|              16 | 2022-08-18       |              3 | Allograft Biopsy Procedure Note                                                                          |
|              16 | 2022-08-18       |              4 | Pathology Report – Chronic Active ABMR (g1 ptc1 cg1, C4d positive)                                       |
|              16 | 2022-08-18       |              5 | Treatment Plan – IVIG + Rituximab; optimize BP & RAAS blockade                                           |
|              17 | 2022-09-20       |              1 | Infusion Center Note – IVIG administration                                                               |
|              17 | 2022-09-20       |              2 | Pharmacy Note – Rituximab infusion and premedication                                                     |
|              18 | 2023-04-05       |              1 | Transplant Nephrology Clinic – CKD Stage 3b; eGFR 32                                                     |
|              18 | 2023-04-05       |              2 | Nephrology Dietitian Note – Low-sodium diet; protein moderation                                          |
|              19 | 2023-11-29       |              1 | Transplant Nephrology Clinic – CKD Stage 4; access planning                                              |
|              20 | 2024-03-14       |              1 | Vascular Surgery Consult – AV Fistula Planning (left radiocephalic)                                      |
|              21 | 2024-04-22       |              1 | Vascular Surgery Operative Note – Left radiocephalic AVF creation                                        |
|              21 | 2024-04-22       |              2 | Anesthesia Post-Procedure Note – uneventful recovery                                                     |
|              22 | 2024-06-10       |              1 | Duplex Ultrasound – AVF maturation assessment                                                            |
|              22 | 2024-06-10       |              2 | Vascular Surgery Clinic – AVF expected ready in 6–8 weeks                                                |
|              23 | 2024-12-04       |              1 | Pre-Dialysis Education – Modality selection; HD chosen                                                   |
|              24 | 2025-02-12       |              1 | ED to Inpatient Admission – Volume overload & hyperkalemia                                               |
|              24 | 2025-02-12       |              2 | Interventional Radiology Procedure Note – Tunneled dialysis catheter placement                           |
|              24 | 2025-02-12       |              3 | Inpatient Nephrology Note – Start hemodialysis; immunosuppression taper strategy                         |
|              25 | 2025-03-03       |              1 | Outpatient Dialysis Unit Admission Note – HD M/W/F schedule                                              |
|              26 | 2025-04-10       |              1 | Dialysis Access Note – First successful AVF cannulation; plan catheter removal                           |
|              27 | 2025-05-22       |              1 | Transplant Nephrology Follow-Up – Taper to low-dose prednisone only                                      |
|              27 | 2025-05-22       |              2 | Sensitization Risk Counseling – Post-graft failure management                                            |
|              28 | 2025-08-07       |              1 | Transplant Re-Listing Evaluation – HLA typing, cPRA & waitlist counseling                                |
|              28 | 2025-08-07       |              2 | Social Work Evaluation – Support, transportation, adherence assessment                                   |